Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2026)
Jasper Therapeutics (JSPR) posted Prepaid Assets of $3.8 million for Q2 2026, down 35.49% on a QoQ basis from $6.0 million in Q4 2025, and up 11.11% year-over-year from $3.5 million in Q2 2025.
Analysis
Jasper Therapeutics (JSPR) Prepaid Assets (2019 - 2026) Analysis & Trends
Jasper Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $3.8 million in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 11.11% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 11.11% increase from a year earlier, with the FY2025 full-year figure at $6.0 million, up 42.62% from the prior year.
- Prepaid Assets was $3.8 million for Q2 2026 at Jasper Therapeutics, down from $6.0 million in the prior quarter.
- The five-year high for Prepaid Assets was $6.0 million in Q4 2025, with the low at $1.4 million in Q3 2023.
- Average Prepaid Assets over 5 years is $3.0 million, with a median of $2.8 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets jumped 2286.63% in 2022, then tumbled 41.02% in 2024.
- Over 5 years, Prepaid Assets stood at $2.8 million in 2022, then retreated by 27.22% to $2.1 million in 2023, then jumped by 103.51% to $4.2 million in 2024, then soared by 42.62% to $6.0 million in 2025, then tumbled by 35.49% to $3.8 million in 2026.
- The last three Prepaid Assets figures came in at $3.8 million (Q2 2026), $6.0 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Jasper Therapeutics | 20.11 Mn | 20.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Mn |
| Dec 31, 2025 | 5.95 Mn |
| Sep 30, 2025 | 3.67 Mn |
| Jun 30, 2025 | 3.46 Mn |
| Mar 31, 2025 | 4.38 Mn |
| Dec 31, 2024 | 4.17 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 1.86 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 2.76 Mn |
| Mar 31, 2023 | 3.11 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 1.46 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 3.13 Mn |
| Sep 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 103,577.00 |